# Cardiovascular Diseases Table #
---
[](https://cardio-balance-ph.store-best.net)
<div style="height:500px;"></div>
## Cough in cardiovascular diseases ##
Ginagamit ito bilang biologically active na pampadagdag sa pagkain - dagdag na pinagmumulan ng mga bitamina - B2, B6, C, mga organikong asido - mansanas, succinic, glutamine. Mga sangkap: malic acid, succinic acid, glutamic acid, badan extract, ascorbic acid, bitamina B2, B6. Cough in cardiovascular disease: A Symptom of great importance
Cough is often accompanied by colds or respiratory illnesses. However, not every cough is caused in the lungs. In some cases, it can be an important Signal for cardiovascular problems and should therefore be taken seriously.
Why cough when heart disease?
In cardiovascular‑no more disease and, in particular, in the case of a heart failure, the heart is sufficiently efficient. It's the blood pumping through the body, making it the veins in the Lungs to a backwater. This leads to an Overload of the pulmonary circulation and the accumulation of fluid in the alveoli (Edema).
The body's response to it, a dry cough — dry and initially insignificant, but later steadily and stressful. Typical characteristics of such a cough are:
Onset or exacerbation during physical exertion;
Gain in lying Position (because of the return flow of Blood increases to the heart);
possible release of foamy, hellrosem mucus in severe cases;
Side effects, such as shortness of breath, swelling of the legs or fatigue.
What is the cardiovascular‑may cause diseases cough?
Not only the heart failure can lead to a cardiac cough. Other diseases are associated with this Symptom:
Heart valve defects: Defective heart valves disrupt the normal flow of blood and can lead to pulmonary edema.
High blood pressure (hypertension): Durable high blood pressure strains the heart and can lead over time to a Left heart failure.
Coronary heart disease (CHD): A decreased blood flow to the heart muscle can interfere with heart function and lead to so indirectly, of congestion of the Lungs.
When should you go to the doctor?
A cough that lasts longer than two weeks, especially if it is accompanied by shortness of breath, chest pain or swelling, is a reason for a medical examination. The doctor can clarify by using various tests, whether the cough has a cardiac cause:
physical examination and medical history;
X-ray of the Thorax;
ECG and echocardiography (ultrasound of the heart);
Blood tests (e.g., the NT‑proBNP, a Marker for congestive heart failure).
Treatment and lifestyle changes
If the cough is due to a cardiovascular disease, the treatment according to the cause. Possible measures are:
Drugs for lowering blood pressure, to the relief of the heart or to the removal of excess fluid (diuretics);
Reduction of salt intake, fluid accumulations to prevent;
regular dose of physical activity;
Weight control and a healthy diet;
Abstinence from Smoking and alcohol.
Conclusion
A persistent cough is not always harmless. Especially in people with existing cardiovascular disease or risk factors such as high blood pressure, it can be an early warning sign. Early diagnosis and targeted treatment can improve the quality of life significantly and prevent any possible complications. So listen to your body and talk to your symptoms with a physician.
Sa pangunahing (esensyal) na altapresyon, ito ay dahil sa impluwensya ng namamana, hilig sa mataas na presyon ng dugo sa konteksto ng hindi malusog na pamumuhay, masamang gawi, hindi malusog na pagkain, na nagdudulot ng labis na timbang. Dagdag pa ang stress, kalikasan, kakulangan sa tulog at aktibidad. Lahat ito ay negatibong nakakaapekto sa trabaho ng puso at sa tono ng mga daluyan ng dugo. Ang presyon ay unang tumataas nang hindi napapansin at pagkatapos ay mas nagiging malinaw.
> Ektrak mula sa prutas ng cranberry Ektrak mula sa prutas ng appleberry Magnesium L-Arginin Ektrak mula sa dahon at bulaklak ng hawthorn Pulbos ng bulaklak ng hibiscus Ektrak mula sa dahon ng oliba Ektrak mula sa buto ng ubas Ektrak mula sa black currant Coenzyme Q10 Bitamina B6 Folate
<a href="https://pad.yuka.dev/s/sgCVVZ8LAA">Anesthesia for cardiovascular disease in adults</a>
Madalas nagtatanong ang mga tao sa mga botika tungkol sa mga gamot laban sa presyon ng bagong henerasyon na walang side effects. Pero sa totoong buhay, hindi ito nangyayari. Lahat ng epektibong gamot ay may kanya-kanyang side effects. Kailangan mong maglaan ng maraming oras kasama ang iyong doktor para piliin ang tamang grupo ng gamot laban sa high blood pressure para sa'yo. <a href="https://hedgedoc.stanleysolutionsnw.com/s/cShHKu67ar">PUMUNTA SA WEBSITE>>> </a> Cardiovascular diseases: Overview and key metrics
Cardiovascular diseases (CVD) represent one of the main causes of morbidity and mortality in industrialized countries. In the Following, an Overview of the most important cardio is presented diseases, as well as some epidemiological and clinical indicators in the Form of a table.
Table: Overview of the most important cardiovascular diseases
Disease name International designation (ICD-10), prevalence (approx., Germany) main risk factors are the main symptoms
Coronary heart disease (CHD) Coronary heart disease I25 ∼5-7% of adult hypertension, hyperlipidemia, Smoking, Diabetes mellitus, Angina, exertional dyspnea, heart attack
Heart failure heart failure I50 ∼2-3% of the population, CHD, hypertension, atrial fibrillation, cardiomyopathies dyspnea, fatigue, Edema (especially on the legs), water accumulation in the abdomen (ascites)
Hypertension hypertension I10–I15 ∼30-35% of the adult population genetics, Obesity, Salt intake, lack of physical activity Often asympomatisch; headache, dizziness, blurred vision (in the case of high values)
Atrial fibrillation atrial fibrillation I48 ∼1-2% of the total population, increases with age, age, hypertension, heart valve defects, thyroid knock overactive heart, inability to bear weight, dizziness, increased risk of stroke
Stroke (cerebrovascular accident) stroke I60–I64 ∼200 per 100000 inhabitants/year, hypertension, Diabetes, atrial fibrillation, Smoking, Sudden paralysis, speech disorders, visual field deficits, disorders of consciousness
Peripheral arterial occlusive disease (paod) leg pain when walking (swing gear) I70.2 ∼5-10% over 60 years, Smoking, Diabetes, hyperlipidemia, pain when walking, the slacking remain Standing (intermittent Klaudikation), cool and pale Fußregionen
A short Interpretation of the table
The above table gives disorders an Overview of the most common cardiovascular, your official ICD‑10 Codes, the estimated prevalence in Germany and the main risk factors and symptoms.
Observations:
High prevalence: high blood pressure and coronary heart diseases are very common and affect a large part of the adult population.
Overlapping risk factors: It is striking that a number of risk factors, particularly hypertension, Diabetes mellitus and Smoking occur in various diseases. This underlines the importance of a common prevention.
Old-age dependency: The incidence of many diseases, such as atrial fibrillation, or peripheral arterial disease increases significantly with age.
Asymptomatic course: Especially in the case of hypertension can for many years do not experience any symptoms, which is why regular checkups are essential in order to prevent consequential damage (e.g., stroke, congestive heart failure).
This Overview serves diseases as a basis for a better understanding of the epidemiology and clinic of cardiovascular and can be used in clinical practice and health policy useful.
## Anesthesia for cardiovascular disease in adults ##
Anesthesia for cardiovascular disease in adults: to minimize risks, maximize safety
In modern medicine, the conduct of operations in patients with cardiovascular represents disease is a particular challenge. Each year, many adults have to go with pre — existing conditions such as coronary heart disease, congestive heart failure or hypertension surgery and the anesthesia plays a Central role in the success and safety of the entire process.
Why is anesthesia in these patients so complex?
Sit there, that the heart and the circulatory system are already pre-loaded, they react more sensitive to the stresses of surgery and anesthesia. Anesthetics can affect blood pressure, heart rate, and cardiac output lead to what in a predisposed patients, complications rule events: from arrhythmic to an acute myocardial infarction or congestive heart failure.
The preparation that decides the Outcome
A thorough preoperative evaluation is essential. This includes:
a detailed patient history with the focus on the heart of symptoms, previous surgeries and medications;
cardiac diagnostics: ECG, echocardiography and, if necessary, stress testing or coronary angiography;
the assessment of operational risk using established scales (e.g., the Revised Cardiac Risk Index);
close collaboration between anesthesiologists, cardiologists and surgeons to individual therapy adjustment.
Strategies for safe anesthesia
The choice of the anesthetic technique depends heavily on the engagement and the health condition of the patient. Options are:
General anesthesia with controlled hemodynamics: modern, volatile anesthetics, and short-acting opioids allow a fine dosage and quick adaptation to changing blood pressure and pulse values.
Regional anesthesia (e.g., Spinal or epidural anesthesia): in case of appropriate interventions, this method can reduce the Stress for the heart and the postoperative pain therapy improve.
Monitoring on high profile level: in addition to the standard monitoring (ECG, blood pressure, oxygen saturation) are used in high-risk patients procedures such as Central venous pressure measurement, or transesophageal echocardiography is used.
Medication management: Balance between Benefit and risk
Certain medications must be discontinued prior to surgery or adjusted. Others — such as beta-blockers or statins should be continued, as they reduce the perioperative cardiac risk. The intraoperative fluid dose, and the use of vasoaktiver substances require special care to prevent Over‑ or Under-utilization of the heart.
Conclusion: Teamwork and individualization is the key to success
Anesthesia in patients with cardiovascular disease is not a standard task as it requires Expertise, planning, and close interdisciplinary cooperation. Through a careful risk assessment, the individual adjustment of the anesthetic strategy, and an intensive Monitoring in the perioperative risk can be significantly reduced. The objective is always to guide the patient through the surgery and to allow a possible complication of poor recovery.
<a href="https://md.sebastians.dev/s/SC6vkR80a">Anesthesia for cardiovascular disease in adults</a> Cardiovascular Diseases Table.
<a href="https://pad.medialepfade.net/s/u8eNg4JBl">Cough in cardiovascular diseases</a>
<a href="https://hackmd.k15.synology.me/s/TtVNxOL0Q">Anesthesia for cardiovascular disease in adults</a>
<a href="https://pads.tobast.fr/s/VjdlPSP9pt">Cardiovascular Disease Literature</a>
<a href="https://hedgedoc.ffmuc.net/s/MfSOwPs9LK">https://hedgedoc.ffmuc.net/s/MfSOwPs9LK</a>
<a href="https://hedgedoc.inqbus.de/s/eHSdaHkBo">https://hedgedoc.inqbus.de/s/eHSdaHkBo</a>
<a href="https://hedgedoc.private.coffee/s/Mxe-LjFXg">https://hedgedoc.private.coffee/s/Mxe-LjFXg</a>
<a href="https://hedgedoc.stanleysolutionsnw.com/s/zfoaGtc7bH">https://hedgedoc.stanleysolutionsnw.com/s/zfoaGtc7bH</a>
<a href="https://pad.mytga.de/s/impOpATTl">https://pad.mytga.de/s/impOpATTl</a>
<a href="https://pad.dominick-leppich.de/s/dX9F5FUB6">https://pad.dominick-leppich.de/s/dX9F5FUB6</a>
<a href="https://pad.multiplace.org/s/rkQWZ6uMfg">https://pad.multiplace.org/s/rkQWZ6uMfg</a>
<a href="https://pad.cttue.de/s/ZzFrN4KFP">https://pad.cttue.de/s/ZzFrN4KFP</a>
<a href="https://md.rappet.xyz/s/AEqLV8wf8U">https://md.rappet.xyz/s/AEqLV8wf8U</a>
<a href="https://doc.spiegie.de/s/HLrlNO6ez">https://doc.spiegie.de/s/HLrlNO6ez</a>
<a href="https://hedgedoc.jcg.re/s/fMVw5Akj1E">https://hedgedoc.jcg.re/s/fMVw5Akj1E</a>
<a href="https://pad.demokratie-dialog.de/s/-lQV4vPxA_">https://pad.demokratie-dialog.de/s/-lQV4vPxA_</a>
<a href="https://doc.fsr.saarland/s/HByX9P7g7m">https://doc.fsr.saarland/s/HByX9P7g7m</a>
<a href="https://md.nolog.cz/s/hM-cJLx0N">https://md.nolog.cz/s/hM-cJLx0N</a>
<a href="https://hedge.amosamos.net/s/twxEETQEpg">https://hedge.amosamos.net/s/twxEETQEpg</a>
<a href="https://hedgedoc.ichmann.de/s/7jqm787dVD">https://hedgedoc.ichmann.de/s/7jqm787dVD</a>
<a href="https://pad.nantes.cloud/s/4TW5ZtO8b8">https://pad.nantes.cloud/s/4TW5ZtO8b8</a>
<a href="https://md.mandragot.org/s/ATNNlbTPUQ">https://md.mandragot.org/s/ATNNlbTPUQ</a>
<a href="https://pads.dgnum.eu/s/gpvkF9wPKm">https://pads.dgnum.eu/s/gpvkF9wPKm</a>
<a href="https://hack.utopia-lab.org/s/tW_PM83Ka">https://hack.utopia-lab.org/s/tW_PM83Ka</a>
<a href="https://doc.interscalar.eu/s/aYzH-vYur">https://doc.interscalar.eu/s/aYzH-vYur</a>
<a href="https://pad.medialepfade.net/s/-2H3pel7b">https://pad.medialepfade.net/s/-2H3pel7b</a>
<a href="https://md.interhacker.space/s/9IwjYspez">https://md.interhacker.space/s/9IwjYspez</a>
<a href="https://doc.projectsegfau.lt/s/jc1lEWjg5_">https://doc.projectsegfau.lt/s/jc1lEWjg5_</a>
<a href="https://hedgedoc.et.aksw.org/s/zu6dygRzv">https://hedgedoc.et.aksw.org/s/zu6dygRzv</a>
<a href="https://md.globenet.org/s/QcHeZapLa">https://md.globenet.org/s/QcHeZapLa</a>
<a href="https://hedgedoc.team23.org/s/lbyaKhXyhj">https://hedgedoc.team23.org/s/lbyaKhXyhj</a>
<a href="https://doc.hkispace.com/s/Dup5RjDCm">https://doc.hkispace.com/s/Dup5RjDCm</a>
<a href="https://hedgedoc.obermui.de/s/G-i8CvrnPv">https://hedgedoc.obermui.de/s/G-i8CvrnPv</a>
<a href="https://omoffice.de/s/r1N4-TufMx">https://omoffice.de/s/r1N4-TufMx</a>
<a href="https://codi.sevenvm.de/s/QBovpcBBE">https://codi.sevenvm.de/s/QBovpcBBE</a>
<a href="https://notas.gaiacoop.tech/s/xji8OYbo4">https://notas.gaiacoop.tech/s/xji8OYbo4</a>
<a href="https://pad.n39.eu/s/Yvt6zBHt9b">https://pad.n39.eu/s/Yvt6zBHt9b</a>
<a href="https://pad.ccc-p.org/s/xxrHZ1OIvH">https://pad.ccc-p.org/s/xxrHZ1OIvH</a>
<a href="https://hedgedoc.ffmuc.net/s/sBWndMoCp7">https://hedgedoc.ffmuc.net/s/sBWndMoCp7</a>
<a href="https://md.cortext.net/s/qUrB554p5">https://md.cortext.net/s/qUrB554p5</a>
<a href="https://doc.neutrinet.be/s/Sxlc74mqg9">https://doc.neutrinet.be/s/Sxlc74mqg9</a>
<a href="https://hdoc.csirt-tooling.org/s/tVc7-8Lfy_">https://hdoc.csirt-tooling.org/s/tVc7-8Lfy_</a>
<a href="https://hedgedoc.nrp-nautilus.io/s/j3u_TJoPW5">https://hedgedoc.nrp-nautilus.io/s/j3u_TJoPW5</a>
<a href="https://md.softwarefreedom.net/s/pXvJrYGbQ">https://md.softwarefreedom.net/s/pXvJrYGbQ</a>
<a href="https://pads.cantorgymnasium.de/s/vnSYfXOwj">https://pads.cantorgymnasium.de/s/vnSYfXOwj</a>
<a href="https://notes.simeonreusch.com/s/4J22Vvb20">https://notes.simeonreusch.com/s/4J22Vvb20</a>
<a href="https://hd.wedler.me/s/a9wRl1j5P">https://hd.wedler.me/s/a9wRl1j5P</a>
<a href="https://hedge.grin.hu/s/fjv5DldR8g">https://hedge.grin.hu/s/fjv5DldR8g</a>
<a href="https://md.eris.cc/s/fpIGCdZ30h">https://md.eris.cc/s/fpIGCdZ30h</a>
<a href="https://pad.gusted.xyz/s/5UhwFBvBu">https://pad.gusted.xyz/s/5UhwFBvBu</a>
<a href="https://md.giplt.nl/s/xquHQ_jwTE">https://md.giplt.nl/s/xquHQ_jwTE</a>
<a href="https://write.frame.gargantext.org/s/SJZEypOMMx">https://write.frame.gargantext.org/s/SJZEypOMMx</a>
<a href="https://pad.aleph.world/s/_G26C3PoT">https://pad.aleph.world/s/_G26C3PoT</a>
<a href="https://pad.hxx.cz/s/6NeLKpbDqT">https://pad.hxx.cz/s/6NeLKpbDqT</a>
<a href="https://md.micronited.de/s/HJjFZp_ffg">https://md.micronited.de/s/HJjFZp_ffg</a>
<a href="https://md.infs.ch/s/46NlTzGPKa">https://md.infs.ch/s/46NlTzGPKa</a>
<a href="https://doc.fung.uy/s/2RECXRx0LK">https://doc.fung.uy/s/2RECXRx0LK</a>
<a href="https://doc.cisti.org/s/S7WztC7n1s">https://doc.cisti.org/s/S7WztC7n1s</a>
<a href="https://hedgedoc.private.coffee/s/fC091nj5q">https://hedgedoc.private.coffee/s/fC091nj5q</a>
<a href="https://pad.fablab-siegen.de/s/__wfuQVi1h">https://pad.fablab-siegen.de/s/__wfuQVi1h</a>
<a href="https://n.jo-so.de/s/rNiXSbX0f">https://n.jo-so.de/s/rNiXSbX0f</a>
<a href="https://pad.yuka.dev/s/Gdw-eIQgJz">https://pad.yuka.dev/s/Gdw-eIQgJz</a>
<a href="https://pad.medialepfade.net/s/5CvtJvb5G">https://pad.medialepfade.net/s/5CvtJvb5G</a>
<a href="https://pad.mytga.de/s/nd_V9z8pW">https://pad.mytga.de/s/nd_V9z8pW</a>
<a href="https://doc.interscalar.eu/s/n4YdOfFAk">https://doc.interscalar.eu/s/n4YdOfFAk</a>
<a href="https://hedgedoc.digilol.net/s/bzpzyYU6tY">https://hedgedoc.digilol.net/s/bzpzyYU6tY</a>
<a href="https://notas.laotra.red/s/GpueKQhWZU">https://notas.laotra.red/s/GpueKQhWZU</a>
<a href="https://doc.gnuragist.es/s/JBUtZe5t8e">https://doc.gnuragist.es/s/JBUtZe5t8e</a>
<a href="https://www.notizen.kita.bayern/s/XrYm51b61u">https://www.notizen.kita.bayern/s/XrYm51b61u</a>
<a href="https://doc.fsr.saarland/s/_a7BMy8qPd">https://doc.fsr.saarland/s/_a7BMy8qPd</a>
<a href="https://docs.localcharts.org/s/qrITRxIWY">https://docs.localcharts.org/s/qrITRxIWY</a>
<a href="https://hedgedoc.ichmann.de/s/A3GBzOxngm">https://hedgedoc.ichmann.de/s/A3GBzOxngm</a>
<a href="https://pads.tobast.fr/s/Hl31dJzEMM">https://pads.tobast.fr/s/Hl31dJzEMM</a>
<a href="https://notes.llgoewer.de/s/607kfCBef">https://notes.llgoewer.de/s/607kfCBef</a>
<a href="https://om-office.de/s/H1OA-adzfl">https://om-office.de/s/H1OA-adzfl</a>
<a href="https://md.sigma2.no/s/G-9Y6eG91">https://md.sigma2.no/s/G-9Y6eG91</a>
<a href="https://md.coredump.ch/s/hLnmWWe1u">https://md.coredump.ch/s/hLnmWWe1u</a>
<a href="https://md.sebastians.dev/s/_ESa0gxiB">https://md.sebastians.dev/s/_ESa0gxiB</a>
<a href="https://pad.koeln.ccc.de/s/vEpLULosF">https://pad.koeln.ccc.de/s/vEpLULosF</a>
<a href="https://dok.kompot.si/s/Ql2WjXklLw">https://dok.kompot.si/s/Ql2WjXklLw</a>
<a href="https://hedgedoc.et.aksw.org/s/rImxO4MJ5">https://hedgedoc.et.aksw.org/s/rImxO4MJ5</a>
<a href="https://edit.leiden.digital/s/Sa3ilU72mX">https://edit.leiden.digital/s/Sa3ilU72mX</a>
<a href="https://hedgedoc.auro.re/s/gKxRjktNaq">https://hedgedoc.auro.re/s/gKxRjktNaq</a>
<a href="https://notes.rabjerg.de/s/B16JfpuzGe">https://notes.rabjerg.de/s/B16JfpuzGe</a>
<a href="https://hedgedoc.syyrell.com/s/UPWtIPVHJn">https://hedgedoc.syyrell.com/s/UPWtIPVHJn</a>
<a href="https://md.gafert.org/s/yOhnYGpj7">https://md.gafert.org/s/yOhnYGpj7</a>
<a href="https://doc.hkispace.com/s/nfShrhwXW">https://doc.hkispace.com/s/nfShrhwXW</a>
<a href="https://hedgedoc.jcg.re/s/-rqm08Lx8G">https://hedgedoc.jcg.re/s/-rqm08Lx8G</a>
<a href="https://hedge.amosamos.net/s/5okcsIpnGi">https://hedge.amosamos.net/s/5okcsIpnGi</a>
<a href="https://docs.snowdrift.coop/s/4BwhsdIfW">https://docs.snowdrift.coop/s/4BwhsdIfW</a>
<a href="https://pad.sra.uni-hannover.de/s/qIzm0Qp-O0">https://pad.sra.uni-hannover.de/s/qIzm0Qp-O0</a>
<a href="https://hedgedoc.inqbus.de/s/WvCREUjz-">https://hedgedoc.inqbus.de/s/WvCREUjz-</a>
<a href="https://hackmd.openmole.org/s/jZ9P26INT">https://hackmd.openmole.org/s/jZ9P26INT</a>
<a href="https://hedgedoc.stanleysolutionsnw.com/s/jRfQgY-x6f">https://hedgedoc.stanleysolutionsnw.com/s/jRfQgY-x6f</a>
## Cardiovascular Disease Literature ##
Literature review:
Cardiovascular Disorders: A Review Of The Literature
Cardiovascular diseases (CVD) are one of the leading causes of death worldwide and represent a major challenge for the health system. This Literature review deals with the current scientific knowledge to disease risk factors, diagnostic methods and treatment strategies for cardiovascular disease.
Risk factors and epidemiology
According to the results of several epidemiological studies of modifiable and non-modifiable risk factors play a crucial role in the pathogenesis of CVD. Among the most important modifiable factors:
Hypertension (blood pressure≥140/90 mmHg),
Hyperlipidemia (elevated concentration of LDL‑cholesterol),
Diabetes mellitus type 2,
Smoking
Overweight and obesity (BMI ≥30 kg/m
2
),
physical inactivity,
unhealthy diet.
Non-modifiable factors include age, gender (men are at the age of 65. Age at greater risk), and family history of early cardiovascular events.
A study by the World Health Organization (WHO, 2023) estimates that more than 17 million deaths each year are due to cardiovascular disease, which accounts for about 30% of all Global deaths.
Diagnostic Procedures
The modern diagnosis of CVD is based on a combination of different methods:
History and physical examination: evaluation of risk factors, symptoms, and cardiovascular signs.
Laboratory analyses: measurement of lipid profiles, blood sugar, kidney values and specific biomarkers such as Troponin and NT‑proBNP.
Electrocardiogram (ECG): for the detection of arrhythmias, signs of ischemia or infarction follow.
Echocardiography: imaging method for the assessment of cardiac structure and function.
Load tests (e.g., treadmill test): for the functional assessment under load.
Coronary angiography: invasive method for direct visualization of narrowings in the coronary arteries.
Therapeutic Approaches
The treatment of CVD includes pharmacological and interventional measures:
Drugs:
Antihypertensive (ACE inhibitors, beta-blockers),
Lipid-Lowering Drugs (Statins),
Antidiabetic agents
Platelet aggregation inhibitors (e.g., acetylsalicylic acid).
Interventional Procedures:
Percutaneous coronary Intervention (PCI) with stent implantation,
Coronary bypass surgery (CABG).
Life style modifications:
Smoking abstinence
a healthy diet (e.g., DASH diet),
regular physical activity (at least 150 minutes of moderate load per week),
Weight control.
Current Research Trends
Recent studies focus on the development of more precise risk stratification methods, the use of Artificial intelligence for the analysis of ECG data, as well as the study of genetic and epigenetic factors in CVD. In addition, new drugs, such as PCSK9 inhibitors for aggressive LDL reduction are investigated intensively.
Conclusion
Scientific progress has led to significant improvements in the prevention, diagnosis and therapy of cardiovascular diseases. Nevertheless, the reduction of risk factors and the promotion of a healthy life style the most important measure to reduce the morbidity and mortality due to CVD. Further research is necessary to optimize individual treatment approaches and to improve the quality of life in a sustainable way.
Sources (Examples)
WHO (2023): Global Health Estimates.
German heart Foundation (2022): guidelines for the prevention of cardiovascular diseases.
European Society of Cardiology (2021): Guidelines on cardiovascular disease prevention.